Dr. Reddy's Launches Deferasirox Tablets In U.S.

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY, DRREDDY) announced Friday the launch of Deferasirox Film-Coated Tablets, 90 mg and 360 mg. It is a therapeutically equivalent generic version of Jadenu (deferasirox) Film-Coated Tablets, 90 mg, 180 mg, and 360 mg, approved by the U.S. Food and Drug Administration.

The Jadenu brand had U.S. sales of approximately $470 million for the most recent twelve months ended in September 2019.

The company also announced the launch of Deferasirox Tablets for Oral Suspension, a therapeutically equivalent generic version of Exjade (deferasirox) Tablets for Oral Suspension, approved by the FDA.

The Exjade brand had U.S. sales of approximately $113 million in a year ended September 2019.

Dr. Reddy's Deferasirox Tablets for Oral Suspension, are available in 125 mg, 250 mg, and 500 mg dosage strengths in bottle count sizes of 30.